Antibodies are the unsung heroes of your immune system, defending your body against harmful invaders with the precision that rivals the most advanced military technology. Let’s take a closer look!
I’m Dreaming of a Glow-in-the-Dark Christmas Tree
Imagine a holiday season where your Christmas tree glows naturally—no tangled strings of lights or electricity required. Advances in biotechnology are turning this dream into a reality.
Therapeutic Antibodies Explained
Antibody therapeutics have revolutionized treatment for many diseases, from cancer to autoimmune disorders. Read on to learn how they work.
Vaccines: Elegant, Powerful, and Lifesaving
Vaccines are the ultimate cheat code for your immune system—arming it to fight deadly germs before you’re ever in danger.
World AIDS Day: Why It Still Matters
December 1 will mark World AIDS Day, a time to spotlight the ongoing fight against HIV/AIDS. HIV doesn’t directly kill people—it’s the opportunistic infections that come with a weakened immune system that are deadly.
Stump the Clumps: Treating Amyloidosis
Amyloid is a protein that builds up in the liver, spleen, and other tissues. When amyloid folds incorrectly, the protein sticks together and forms fibrous deposits in and around cells, causing amyloidosis. Fortunately, affected patients are benefitting from new, cutting-edge treatment options.
Special Delivery: Gene Therapy Vectors
There are two broad approaches to gene therapy treatment, in vivo and ex vivo, and each relies on a different gene vector to get the job done. Let’s take a closer look.
Branches of Biotechnology
Biotechnology uses living organisms or their components to address many of our largest global challenges in healthcare, agriculture, the environment, and industry.
Biotech vs. Biopharma: Understanding the Differences
Biotechnology, pharmaceuticals, and biopharmaceuticals: these terms and abbreviations (biotech, pharma, and biopharma, respectively) are everywhere in today’s lexicon. However, which aspect of research does each term refer to, and more importantly, how are they different?
AI Boosts Biologic Breakthroughs
The biopharmaceutical landscape is rapidly expanding at a CAGR of 12.5%, with its market value set to rise from USD 333.09 billion in 2022 to USD 856.1 billion by 2030.
